The Ann Arbor-based biotech startup will use the funding to develop its microbubble technology that allows for removal of biomolecules from biological samples.
The company also received a grant from the Maryland Innovation Initiative to help advance the device toward commercialization.
Separately, FlowJo and Cytapex Bioinformatics said they have partnered to provide bioinformatics consulting and services for flow cytometry data analysis.
The institute will work with other HCA members to build a data-coordination platform for the initiative's researchers.
Eleven new studies from the NHLBI NextGen Consortium show different uses for iPSCs to study polygenetic diseases across various systems in the human body.
Bioké will exclusively distribute Acea's xCelligence cell analyzer in Belgium, the Netherlands, and Luxembourg.
The technique provides the scientific community with a higher-resolution methodology to determine if a mouse cell line has been correctly identified in research.
The worldwide distribution agreement expands Oxford's existing product and service portfolio, streamlining workflows for current customers, the company said.
The deal covers Biolog's line of cell analysis tools including its Gen III MicroPlate test panel for bacterial species identification.
The company plans to use the funds to support the worldwide launch of its commercial platform for propagation and gene editing in cell types that are difficult to transfect.
Funded by a $600 million gift, the Biohub will support investigators at three universities as well as two initial internal projects.
The results begin to adress questions about whether the company's meticulous, but costly research services can actually impact patient outcomes.
The partners will use Namocell's Single Cell Dispenser platform for cell sorting and to capture CTCs.
The grant, made through Innovate UK, will specifically fund a collaboration between Oxford Genetics and researchers at the University of Oxford.
Analysis of a gene associated with basal progenitor cell expansions in the brain suggests a single splice site change led to human-specific forms of the gene transcript.
The cell lines were edited with CRISPR/Cas9 to create fusions of GFP with the proteins of interest, allowing researchers to image structures in real time.
The researchers said their one-step, inducible, multiplex gene knockdown and gene knockout platforms can be used in many differentiated cell types.
Thermo Fisher said the deal strengthens its portfolio for stem cell research, and it will fold MTI-GlobalStem into its life sciences solutions segment.
Sales of Helios instruments and genomics analytical consumables were lower than expected, pulling down revenues.
A team of Austrian scientists used their new screening method to investigate genes and transcription factors regulating T cell receptor signaling.
Magdalena Skipper, the incoming editor-in-chief of Nature, speaks with NPR's Weekend Edition Sunday.
Genetic genealogy has led to an arrest in another cold case, dating back to 1987.
In PLOS this week: mutation in second gene widens clinical symptoms of people with ADD3 mutations, comparative genomic analysis of Pseudovibrio, and more.
Wired reports that 23andMe is trying to bolster its outside collaborations.